Jakavi Oral Solution for Children 0.5% (Ruxolitinib phosphate) from Novartis Pharma, YJ code 4291034S1027 (0.5%1mL), is used to treat certain blood disorders like myelofibrosis and polycythemia vera. It is also indicated for graft-versus-host disease in adults and children 12 years of age and older.
Jakavi Oral Solution for Children 0.5%
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
